Korro Bio (KRRO) EPS (Diluted) (2022 - 2026)
Powered by 
Analysis
Korro Bio (KRRO) EPS (Diluted) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.46 Bn | 192.47 Bn | 7.24 Bn | 4.37 |
| 2 | Gilead Sciences | 179.92 Bn | 176.75 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 131.37 Bn | 123.51 Bn | 2.84 Bn | 4.31 |
| 4 | Regeneron Pharmaceuticals | 81.86 Bn | 73.87 Bn | 3.93 Bn | 12.23 |
| 5 | Argenx Se | 60.29 Bn | 55.10 Bn | 1.37 Bn | 7.15 |
| 6 | Moderna | 53.76 Bn | 48.62 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.16 Bn | 29.85 Bn | 992.69 Mn | 1.19 |
| 8 | Biogen | 31.90 Bn | 30.62 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.13 Bn | 29.13 Bn | 1.16 Mn | -0.40 |
| 10 | Korro Bio | 225.43 Mn | 110.39 Mn | - | -1.07 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.07 |
| Mar 31, 2026 | -1.69 |
| Dec 31, 2025 | -2.78 |
| Sep 30, 2025 | -1.92 |
| Jun 30, 2025 | -2.74 |
| Mar 31, 2025 | -2.49 |
| Dec 31, 2024 | -0.40 |
| Sep 30, 2024 | -2.26 |
| Jun 30, 2024 | -2.43 |
| Mar 31, 2024 | -2.44 |
| Dec 31, 2023 | -16.63 |
| Sep 30, 2023 | -25.04 |
| Jun 30, 2023 | -63.83 |
| Mar 31, 2023 | -72.20 |
| Dec 31, 2022 | 24.24 |
| Sep 30, 2022 | -27.73 |